Key result
The Molecular Microscope Diagnostic System identified T-cell-mediated rejection in a heart transplant recipient with bradycardia and a nondiagnostic endomyocardial biopsy, enabling successful treatment.
Why the study?
Can artificial intelligence aid in the diagnosis and management of rejection in heart transplant recipients when traditional techniques are inconclusive?
Case Report (n=1)
No
Can artificial intelligence aid in the diagnosis and management of rejection in heart transplant recipients when traditional techniques are inconclusive?
Answers are grounded in this paper and cite their sources.
Artificial intelligence may assist in diagnosing heart transplant rejection when traditional biopsy results are inconclusive.
Transplant recipients are at risk of developing rejection that may cause significant morbidity and mortality following transplantation The clinical presentation of rejection may be atypical, leading to difficulties in diagnosis and management especially in cases with a nondiagnostic biopsy specimen. The emergence of artificial intelligence may aid in clinical decision making when traditional techniques are inconclusive.
No takes yet. Share an insight, caveat, or question.
Alam et al. (2021) conducted a case report in Heart transplant rejection (n=1). Molecular Microscope Diagnostic System (MMDx) vs. Endomyocardial biopsy (EMB) was evaluated on Detection of transplant rejection. The Molecular Microscope Diagnostic System identified T-cell-mediated rejection in a heart transplant recipient with bradycardia and a nondiagnostic endomyocardial biopsy, enabling successful treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: